HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 1 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,996,000 | +8.9% | 10,000,000 | 0.0% | 0.08% | +26.2% |
| Q1 2022 | $17,436,000 | -0.7% | 10,000,000 | 0.0% | 0.06% | -1.5% |
| Q4 2021 | $17,559,000 | -1.5% | 10,000,000 | 0.0% | 0.07% | -15.4% |
| Q3 2021 | $17,822,000 | -8.9% | 10,000,000 | 0.0% | 0.08% | -12.4% |
| Q2 2021 | $19,564,000 | +6.4% | 10,000,000 | 0.0% | 0.09% | -11.0% |
| Q1 2021 | $18,389,000 | – | 10,000,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |